Coherus Oncology, Inc.
CHRS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001512762
No open-market purchases or sales by Coherus Oncology, Inc. insiders were filed in the last 90 days; 146 institutions reported holding it in 13F filings for Q2 2026, worth $98.5M in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, −10 vs. previous quarter
- 146
- 13F valueReported value at the end of Q2 2026
- $98.5M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding CHRS, Q2 2026
No superinvestor reported holding CHRS at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Coherus Oncology, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 28, 2025 (view filing) | May 23 | 5 days | Wahlstrom MatsDirector | SSale | −100.0K | $0.74 | −$74.0K | −100.0%0 after | |
| Nov 24, 2023 (view filing) | Nov 22 | 2 days | Lanfear Dennis MPresident & CEO | SSale | −223.1K | $2.02 | −$450.7K | −23.4%731.7K after | |
| Oct 19, 2021 (view filing) | Oct 15 | 4 days | Stilwell McDavidChief Financial Officer | SSale | −3.51K | $16.80 | −$58.9K | −10.0%31.6K after | |
| Sep 29, 2021 (view filing) | Sep 27-29 | 2 days | Healy JamesDirector | SSaleCommon Stock, $0.0001 par value | −434.6K | $16.68 | −$7.25M | −100.0%0 after | 3 lots |
Top 10 13F holders, Q2 2026
The largest institutional positions in Coherus Oncology, Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Timothy G. Youngquist 2020 Irrevocable Trust | 13,050,623 | $18.3M | 3.67% | +759,823+6.2% | Added |
| BlackRock, Inc. | 12,003,316 | $16.8M | 0.00% | +1,638,242+15.8% | Added |
| Vanguard Capital Management LLC | 5,949,490 | $8.33M | 0.00% | +496,728+9.1% | Added |
| Geode Capital Management, LLC | 3,685,567 | $5.16M | 0.00% | +563,989+18.1% | Added |
| Samsara BioCapital, LLC | 3,428,571 | $4.80M | 0.39% | 00.0% | Unchanged |
| Kohlberg Kravis Roberts & Co. L.P. | 3,036,076 | $4.18M | 0.07% | 00.0% | Unchanged |
| State Street Corp | 2,382,305 | $3.34M | 0.00% | +56,446+2.4% | Added |
| Two Sigma Investments, LP | 2,259,412 | $3.16M | 0.00% | −42,589−1.9% | Reduced |
| CM Management, LLC | 2,100,000 | $2.94M | 1.87% | 00.0% | Unchanged |
| C WorldWide Group Holding A/S | 1,928,464 | $2.70M | 0.07% | 00.0% | Unchanged |